ACRS - Why Is Dermatology Focused Aclaris Therapeutics Stock Trading Higher Today? | Benzinga

Aclaris Therapeutics Inc (NASDAQ:ACRS) has announced leadership changes as the company undertakes a strategic review of its business.

Aclaris and Douglas Manion have reached a mutual agreement for him to immediately step down from his roles as Chief Executive Officer, President, and Board Member at Aclaris.

Also Read: Analyst Highlights Aclaris Therapeutics’ Encouraging Efficacy For Eczema Candidate, But Cautions On Data Variations.

In connection with his departure, the Board has appointed Neal Walker, Aclaris’ Chairman of the Board of ...

Full story available on Benzinga.com